Hao Sea Biology Technology (06826.HK) controlling shareholder Jiang Wei involved in insider trading and was filed by the Securities Regulatory Commission. The company stated that it does not involve its own stock and its operations have not been significantly affected.

The Zhixun Financial APP announced that Hao Hai Bioscience Technology (06826.HK) issued a notice that the company has received a "Notice of Filing" (No. ZJLA Letter 0382025016) issued by the China Securities Regulatory Commission (hereinafter referred to as the "CSRC") recently. Mr. Jiang Wei, one of the controlling shareholders and actual controllers, for alleged insider trading, according to the "Securities Law of the People's Republic of China" and the "Administrative Penalty Law of the People's Republic of China" and other legal regulations, has decided to file a case against them. The company understands that this matter has nothing to do with the company's stock.